Anteilseigner
Syncona Investment Management Ltd. (27,08 %) Forbion Capital Partners Management Holding BV (5,84 %) Redmile Group LLC (3,93 %) Vestal Point Capital LP (3,66 %) OrbiMed Advisors Private Equity (3,57 %) Ikarian Capital LLC (3,53 %) StemPoint Capital LP (3,38 %) Baker Bros. Advisors LP (2,95 %) Renaissance Technologies LLC (2,46 %) Invus Public Equities Advisors LLC (1,85 %) Boothbay Fund Management LLC (1,03 %) Acadian Asset Management LLC (0,69 %) Citadel Securities LLC (0,26 %) HRT Financial LLC (0,09 %) Geode Capital Management LLC (0,05 %) Virtu Americas LLC (0,05 %) Millennium Management LLC (0,05 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,04 %)
Kontakt
Achilles Therapeutics PLC